We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Eastman Chemical's Q2 Earnings and Revenues Miss, Down Y/Y
Read MoreHide Full Article
Key Takeaways
EMN posted Q2 adjusted EPS of $1.60, down from $2.15 last year and below the consensus estimate.
Eastman Chemical's Q2 sales fell 3% year over year to $2.29B, missing estimates amid weak end-market demand.
EMN expects Q3 adjusted EPS of $1.25 and full-year operating cash flow of approximately $1 billion.
Eastman Chemical Company (EMN - Free Report) logged second-quarter 2025 earnings of $1.20 per share, a roughly 38% decline from the year-ago quarter's figure of $1.94.
EMN posted adjusted earnings of $1.60 per share, down from the year-ago quarter figure of $2.15. It lagged the Zacks Consensus Estimate of $1.72.
The company’s revenues in the second quarter were $2,287 million, down around 3% year over year. It missed the Zacks Consensus Estimate of $2,289.9 million.
EMN faced significant challenges in the second quarter and only saw a modest sign of seasonal improvement across its end markets. It took actions to mitigate the economic impact of the increased level of tariffs through continued commercial excellence and supply-chain initiatives.
Eastman Chemical Company Price, Consensus and EPS Surprise
Advanced Materials: Sales from the segment fell 2% year over year to $777 million in the reported quarter. The figure beat our estimate of $770 million. Sales revenues declined due to lower sales volume and mix resulting from weak demand in key end markets.
Additives & Functional Products: Sales from the segment were $769 million, reflecting an upside of 7% from the year-ago quarter. The figure topped our estimate of $732 million. Sales were driven by higher selling prices, improved sales volume and mix, and favorable foreign currency exchange fluctuations.
Chemical Intermediaries: Sales from the segment were down 10% year over year to $463 million. The figure missed our estimate of $529 million. Sales declined due to lower sales volume and mix and reduced selling prices.
Fibers: The segment reported sales of $274 million, down 17% year over year. The figure beat our estimate of $252 million. Sales declined primarily due to lower sales volume and mix.
EMN’s Financials
The company ended the quarter with cash and cash equivalents of $423 million. Net debt was $4,703 million.
Cash provided by operating activities was $233 million, down around 37% year over year. EMN returned $145 million to shareholders through dividends and share repurchases in the reported quarter.
EMN’s Guidance
EMN noted that it is seeing a challenging global macroeconomic environment entering the second half. Customers are increasingly cautious due to a changing tariff environment and soft demand. The company expects to gain from the ramp-up of cost-reduction initiatives and higher revenues from its Kingsport methanolysis facility.
EMN sees third-quarter adjusted earnings to be roughly $1.25 per share. It also expects to generate an operating cash flow of around $1 billion for the full year.
EMN’s Price Performance
EMN’s shares are down 25.5% over a year compared with a 22.8% decline recorded by the Zacks Chemicals Diversified industry.
Image Source: Zacks Investment Research
EMN’s Zacks Rank & Key Picks
EMN currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks worth a look in the basic materials space include Royal Gold, Inc. (RGLD - Free Report) , Avino Silver & Gold Mines Ltd. (ASM - Free Report) and Barrick Mining Corporation (B - Free Report) .
Royal Gold is slated to report second-quarter results on Aug 6. The Zacks Consensus Estimate for earnings is pegged at $1.70. RGLD beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 9%. RGLD carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Avino Silver is scheduled to report second-quarter results on Aug 13. The Zacks Consensus Estimate for ASM’s second-quarter earnings is pegged at 3 cents. ASM beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 104.2%. ASM currently carries a Zacks Rank #1.
Barrick Mining is slated to report second-quarter results on Aug 11. The consensus estimate for Barrick’s earnings is pegged at 47 cents. Barrick, carrying a Zacks Rank #1, beat the consensus estimate in three of the last four quarters, with the average earnings surprise being 12.5%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Eastman Chemical's Q2 Earnings and Revenues Miss, Down Y/Y
Key Takeaways
Eastman Chemical Company (EMN - Free Report) logged second-quarter 2025 earnings of $1.20 per share, a roughly 38% decline from the year-ago quarter's figure of $1.94.
EMN posted adjusted earnings of $1.60 per share, down from the year-ago quarter figure of $2.15. It lagged the Zacks Consensus Estimate of $1.72.
The company’s revenues in the second quarter were $2,287 million, down around 3% year over year. It missed the Zacks Consensus Estimate of $2,289.9 million.
EMN faced significant challenges in the second quarter and only saw a modest sign of seasonal improvement across its end markets. It took actions to mitigate the economic impact of the increased level of tariffs through continued commercial excellence and supply-chain initiatives.
Eastman Chemical Company Price, Consensus and EPS Surprise
Eastman Chemical Company price-consensus-eps-surprise-chart | Eastman Chemical Company Quote
EMN’s Segment Highlights
Advanced Materials: Sales from the segment fell 2% year over year to $777 million in the reported quarter. The figure beat our estimate of $770 million. Sales revenues declined due to lower sales volume and mix resulting from weak demand in key end markets.
Additives & Functional Products: Sales from the segment were $769 million, reflecting an upside of 7% from the year-ago quarter. The figure topped our estimate of $732 million. Sales were driven by higher selling prices, improved sales volume and mix, and favorable foreign currency exchange fluctuations.
Chemical Intermediaries: Sales from the segment were down 10% year over year to $463 million. The figure missed our estimate of $529 million. Sales declined due to lower sales volume and mix and reduced selling prices.
Fibers: The segment reported sales of $274 million, down 17% year over year. The figure beat our estimate of $252 million. Sales declined primarily due to lower sales volume and mix.
EMN’s Financials
The company ended the quarter with cash and cash equivalents of $423 million. Net debt was $4,703 million.
Cash provided by operating activities was $233 million, down around 37% year over year. EMN
returned $145 million to shareholders through dividends and share repurchases in the reported quarter.
EMN’s Guidance
EMN noted that it is seeing a challenging global macroeconomic environment entering the second half. Customers are increasingly cautious due to a changing tariff environment and soft demand. The company expects to gain from the ramp-up of cost-reduction initiatives and higher revenues from its Kingsport methanolysis facility.
EMN sees third-quarter adjusted earnings to be roughly $1.25 per share. It also expects to generate an operating cash flow of around $1 billion for the full year.
EMN’s Price Performance
EMN’s shares are down 25.5% over a year compared with a 22.8% decline recorded by the Zacks Chemicals Diversified industry.
Image Source: Zacks Investment Research
EMN’s Zacks Rank & Key Picks
EMN currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks worth a look in the basic materials space include Royal Gold, Inc. (RGLD - Free Report) , Avino Silver & Gold Mines Ltd. (ASM - Free Report) and Barrick Mining Corporation (B - Free Report) .
Royal Gold is slated to report second-quarter results on Aug 6. The Zacks Consensus Estimate for earnings is pegged at $1.70. RGLD beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 9%. RGLD carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Avino Silver is scheduled to report second-quarter results on Aug 13. The Zacks Consensus Estimate for ASM’s second-quarter earnings is pegged at 3 cents. ASM beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 104.2%. ASM currently carries a Zacks Rank #1.
Barrick Mining is slated to report second-quarter results on Aug 11. The consensus estimate for Barrick’s earnings is pegged at 47 cents. Barrick, carrying a Zacks Rank #1, beat the consensus estimate in three of the last four quarters, with the average earnings surprise being 12.5%.